63 related articles for article (PubMed ID: 38493445)
1. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?
Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ
Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications and molecular features of extracellular matrix networks in soft tissue sarcomas.
Pankova V; Krasny L; Kerrison W; Tam YB; Chadha M; Burns J; Wilding CP; Chen L; Chowdhury A; Perkins E; Lee ATJ; Howell L; Guljar N; Sisley K; Fisher C; Chudasama P; Thway K; Jones RL; Huang PH
Clin Cancer Res; 2024 May; ():. PubMed ID: 38810090
[TBL] [Abstract][Full Text] [Related]
3. CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises.
Tong B; Wang M
Future Oncol; 2018 Sep; 14(21):2179-2188. PubMed ID: 29667847
[TBL] [Abstract][Full Text] [Related]
4. [Latest Findings on the Role of CD47 in Tumor Immune Evasion and Related Targeted Therapies].
Jie XL; Kong YY; Zhou GB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):455-461. PubMed ID: 37248568
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments.
Benesova I; Capkova L; Ozaniak A; Pacas P; Kopeckova K; Galova D; Lischke R; Buchler T; Ozaniak Strizova Z
J Cancer Res Clin Oncol; 2024 Mar; 150(3):134. PubMed ID: 38493445
[TBL] [Abstract][Full Text] [Related]
6. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
[TBL] [Abstract][Full Text] [Related]
7. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
8. A novel anti-CD47-targeted blockade promotes immune activation in human soft tissue sarcoma but does not potentiate anti-PD-1 blockade.
Ozaniak A; Smetanova J; Bartolini R; Rataj M; Capkova L; Hacek J; Fialova M; Krupickova L; Striz I; Lischke R; Bartunkova J; Strizova Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3789-3801. PubMed ID: 35986756
[TBL] [Abstract][Full Text] [Related]
9. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.
Boudin L; de Nonneville A; Finetti P; Mescam L; Le Cesne A; Italiano A; Blay JY; Birnbaum D; Mamessier E; Bertucci F
J Transl Med; 2022 Oct; 20(1):464. PubMed ID: 36221119
[TBL] [Abstract][Full Text] [Related]
10. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor.
Tanaka K; Miyoshi H; Kawamoto K; Shimasaki Y; Nakashima K; Imamoto T; Yamada K; Takeuchi M; Moritsubo M; Furuta T; Kohno K; Tamura S; Sonoki T; Ohshima K
Pathology; 2024 Feb; 56(1):81-91. PubMed ID: 38110323
[TBL] [Abstract][Full Text] [Related]
12. M1/M2 macrophages and their overlaps - myth or reality?
Strizova Z; Benesova I; Bartolini R; Novysedlak R; Cecrdlova E; Foley LK; Striz I
Clin Sci (Lond); 2023 Aug; 137(15):1067-1093. PubMed ID: 37530555
[TBL] [Abstract][Full Text] [Related]
13. Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer.
Myint ZW; Chahine Z; Jayswal R; Bachert E; McDonald RJ; Strup SE; James AC; Hensley PJ; Allison DB
J Pers Med; 2023 May; 13(6):. PubMed ID: 37373873
[TBL] [Abstract][Full Text] [Related]
14. The Immune Contexture of Liposarcoma and Its Clinical Implications.
Resag A; Toffanin G; Benešová I; Müller L; Potkrajcic V; Ozaniak A; Lischke R; Bartunkova J; Rosato A; Jöhrens K; Eckert F; Strizova Z; Schmitz M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230502
[TBL] [Abstract][Full Text] [Related]
15. Loss of CD47 alters CD8+ T cell activation
Nath PR; Pal-Nath D; Kaur S; Gangaplara A; Meyer TJ; Cam MC; Roberts DD
Oncoimmunology; 2022; 11(1):2111909. PubMed ID: 36105746
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]